GLP1R and glomerulosclerosis: In mice with 5/6 nephrectomy, the reductions in tubulointerstitial fibrosis and glomerulosclerosis resulting from linagliptin treatment occurred even in Glp1r−/− animals, indicating that these renoprotective effects were independent of GLP-1 signaling [72].